Internal Medicine, Cardiovascular Disease · Philadelphia, PA
NPI
1407145592
Since 2011
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
51 N 39th St
Philadelphia, PA, 19104
Phone (215) 662-9189
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
2,707 services
Medicare patients, 2024
1,107
Average age 74
Drug cost, 2024
$618K
2,870 prescriptions
Company payments, 2025
$1,939
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roy V Arjoon was code 93010 (electrocardiogram), 442 times for 334 patients. In total Roy V Arjoon billed 2,707 services in 41 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 442 | 334 | $6.05 | $2,673 |
| 93306 Echocardiography (TTE/TEE) | Office | 206 | 206 | $153.26 | $32K |
| 93306 Echocardiography (TTE/TEE) | Facility | 202 | 201 | $52.10 | $11K |
| 93356 Echocardiography (TTE/TEE) | Office | 191 | 191 | $29.96 | $5,722 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 159 | 121 | $12.56 | $1,996 |
| 99214 Office E&M - Established | Office | 141 | 113 | $84.63 | $12K |
| 93000 Electrocardiogram | Office | 138 | 120 | $10.16 | $1,402 |
| 76376 CT Scan | Office | 120 | 120 | $21.05 | $2,526 |
| 93356 Echocardiography (TTE/TEE) | Facility | 94 | 94 | $8.85 | $831 |
| 76376 CT Scan | Facility | 84 | 84 | $7.49 | $629 |
| 99291 Critical Care E&M | Facility | 83 | 31 | $170.46 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 71 | 54 | $12.94 | $919 |
| 99232 Hospital E&M - Subsequent | Facility | 70 | 37 | $61.46 | $4,302 |
| 93325 Echocardiography (TTE/TEE) | Facility | 63 | 62 | $2.35 | $148 |
| 99214 Office E&M - Established | Facility | 54 | 42 | $72.34 | $3,906 |
By year: 2022 $138K for 2,236 services; 2023 $121K for 2,142 services; 2024 $141K for 2,707 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roy V Arjoon prescribed most often to Medicare patients was Rosuvastatin Calcium, with 502 prescriptions and refills. In total Roy V Arjoon wrote 2,870 Medicare prescriptions that cost $618K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 502 | 1,420 | 153 | $8,717 |
| Metoprolol Succinate Generic | 208 | 596 | 76 | $3,628 |
| Amlodipine Besylate Generic | 206 | 557 | 68 | $1,372 |
| Atorvastatin Calcium Generic | 184 | 490 | 56 | $3,227 |
| Eliquis Apixaban | 173 | 346 | 42 | $194K |
| Carvedilol Generic | 155 | 448 | 53 | $1,472 |
| Valsartan Generic | 152 | 441 | 54 | $7,046 |
| Repatha Sureclick Evolocumab | 101 | 115 | 15 | $63K |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 88 | 236 | 26 | $5,030 |
| Entresto Sacubitril/Valsartan | 79 | 193 | 25 | $123K |
| Olmesartan Medoxomil Generic | 71 | 185 | 31 | $1,483 |
| Jardiance Empagliflozin | 62 | 138 | 20 | $79K |
| Hydrochlorothiazide Generic | 61 | 154 | 21 | $269 |
| Ezetimibe Generic | 59 | 176 | 22 | $2,399 |
| Torsemide Generic | 52 | 138 | 17 | $987 |
Brand drugs: 546 claims; generic drugs: 2,324 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roy V Arjoon $1,939 ($1,939 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbott Laboratories with $1,707.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.